Its ability to induce potent cytotoxicity in cancer cell lines, particularly MDA-MB-231 and T98G, while minimizing damage to hGF and ARPE-19 cells, suggests the presence of compounds with tumor-preferential activity. This evidence concerns the gene HGF and cancer.